CIK 0001661181
- Accelerated filer
Organogenesis Holdings Inc.
Sign in to watch- Ticker
- ORGO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-575-0775
- Business address
- 85 DAN ROAD, CANTON, MA, 02021
- Former names
- Avista Healthcare Public Acquisition Corp.
- 4 Open-market sale President and CEO sold 226,804 shares at an average $5.75 ($1,304,173)
- 4 Open-market sale President and CEO sold 197,336 shares at an average $5.68 ($1,120,557)
- 4 Open-market sale President and CEO sold 263,689 shares at an average $5.77 ($1,521,845)
- 4 Open-market buy 10% owner bought 10,000 shares at an average $6.03 ($60,298)
- 4 Open-market sale President and CEO sold 314,837 shares at an average $6.02 ($1,895,558)
- 4 Grant or award Director acquired 23,913 shares (grant or award)
- 4 Grant or award Director acquired 23,913 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Commercial Officer gave up 1,977 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 9,789 shares (to pay taxes)
- 4 Shares withheld for taxes Vice President, Health Policy gave up 2,738 shares (to pay taxes)
- 4 Shares withheld for taxes VP and General Counsel gave up 2,984 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 2,497 shares (to pay taxes)
- 4 Open-market sale Vice President, Health Policy sold 107,436 shares at an average $8.40 ($902,688)
- 4 Grant or award Director acquired 20,547 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 20,547 shares (grant or award)
- 4 Grant or award Director acquired 20,547 shares (grant or award)
- 4 Grant or award Director acquired 20,547 shares (grant or award)
Page 8 of 17 · 321 filings